甲通过增强抗氧化能力,抑制肝脏BCAA降解途径和肠道微生物群调节来改善肥胖症
Ruili Pan1,2, Ping Wu1,2, Yifan Zhang1,3
1Institute of Food Nutrition and Quality Safety, College of Life Sciences, China Jiliang University, Hangzhou 310018, China. zhaojin@cjlu.edu.cn.
Food & function
|February 25, 2026
概括
黑茶中的叶黄素通过减少氧化压力,改善分支链氨基酸代谢,平衡肠道细菌来对抗肥胖. 这些发现突出了aflavins.
科学领域:
- 代谢学和营养科学
- 微生物学和肠道健康
- 细胞生物学和氧化压力
背景情况:
- 肥胖和代谢障碍是全球重要的健康问题.
- 黑茶中的多烯,茶叶黄素 (TFs),在治疗代谢疾病方面表现有前途.
- 了解肥胖中的TF机制需要调查氧化应激,BCAA代谢和肠道微生物群.
研究的目的:
- 为了研究TFs对高脂肪饮食 (HFD) 诱导的肥胖的影响.
- 阐明涉及氧化应激,BCAA降解和肠道微生物群调节的潜在机制.
- 评估TF作为对代谢疾病的饮食干预措施的潜力.
主要方法:
- 在体外评估TFs的抗氧化能力.
- 在体内研究使用HFD诱导的肥胖小鼠模型与TF的管理.
- 分析肝氧化应激标志物,BCAA通路基因/蛋白质表达和肠道微生物群组成.
- 关联分析整合了代谢,分子和微生物数据.
主要成果:
- 在实验室中,TFs表现出强大的自由基清除活性.
- 在体内,TFs减少了HFD诱导的体重增加,脂质不良,葡萄糖不耐受性和肝脏肥胖症.
- TFs抑制了肝脏氧化应激,降低了肝脏BCAAs降解途径基因/蛋白质的调节,并改善了肝脏功能.
- TF治疗恢复了肠道微生物群平衡,增加了有益的酸盐生产者,减少了有害细菌.
- 在TF诱导的微生物转移,代谢改善和减少BCAA代谢之间发现了显著的相关性.
结论:
- 茶叶黄素通过增强抗氧化能力,正常化肝脏BCAA代谢和调节肠道微生物平衡来缓解HFD诱导的肥胖症.
- TFs代表了对代谢疾病的潜在饮食干预.
- 多方面的机制是TFs在肥胖管理中的有益影响的基础.
更多相关视频
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
1.9K
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
2.8K
相关概念视频
01:30Regulation of Food Intake
3.0K
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
3.0K
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
247
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
247
01:24Obesity
1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
01:19Regulation of Metabolism
11.9K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
11.9K